Ifeoma Felicia Chukwuma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ifeoma Felicia Chukwuma has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Florence Nkechi Nworah
Department of Biochemistry, Faculty of Biological Sciences, University of Nigeria, Nsukka 410001, Nigeria
6 shared publications Florence Nkechi Nworah
University of Nigeria
4 shared publications- Timothy Prince Chidike Ezeorba
Department of Biochemistry, Faculty of Biological Sciences, University of Nigeria, Nsukka, Nigeria
4 shared publications Victor Onukwube Apeh
Federal University of Allied Health Sciences, Enugu, Enugu Nigeria
4 shared publications- Victor Onukwube Apeh
Federal College of Dental Technology and Therapy, Enugu, Nigeria
4 shared publications - Abayomi Emmanuel Adegboyega
Department of Biological Sciences, Structural and Computational Biology, Purdue University, West Lafayette, IN 47907, USA
3 shared publications
Latest Publications
- Open Access
- 19 March 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (3) , e02832
Vitex Simplicifolia Abates Cadmium‐Induced Cardiotoxicity Through Antioxidant Activity and Keap1 Targeting
This study evaluated the cardioprotective potential of Vitex simplicifolia methanol extract (VSME) and explored its underlying mechanisms of action. Twenty‐five male rats were assigned to five groups (n = 5). Group 1 served as the normal control, while groups 2–5 were exposed to 5 mg/kg body weight of cadmium chloride (CdCl 2 ) daily. Group 2 received no treatment, whereas groups 3 and 4 were treated with 200 and 400 mg/kg VSME, respectively, and group 5 received 10 mg/kg propranolol (standard drug), all for 21 days via oral administration. Biochemical and histopathological analyses of the heart were conducted post‐treatment. Cadmium exposure significantly elevated cardiac malondialdehyde, triglycerides, cholesterol, low‐density lipoprotein, creatine kinase, lactate dehydrogenase, and C‐reactive protein, while reducing high‐density lipoprotein, superoxide dismutase (SOD), catalase, and glutathione peroxidase. VSME treatment reversed these changes, restoring antioxidant status, lipid profile, cardiac biomarkers, and myocardial architecture. Molecular docking revealed strong binding affinities of VSME phytochemicals (kaempferol, isorhamnetin, luteolin) with Kelch‐like ECH‐associated protein 1 (Keap1), primarily through hydrogen bonds. These compounds exhibited superior drug‐likeness, pharmacokinetics, and safety profiles compared to the standard Keap1 inhibitor, CPUY192018. These findings suggest that VSME may exert cardioprotective effects partly through antioxidant activity and potential interference with the Keap1‐Nrf2 interaction, as supported by molecular docking.
- 19 March 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (3) , e02832
Open AccessVitex Simplicifolia Abates Cadmium‐Induced Cardiotoxicity Through Antioxidant Activity and Keap1 Targeting
This study evaluated the cardioprotective potential of Vitex simplicifolia methanol extract (VSME) and explored its underlying mechanisms of action. Twenty‐five male rats were assigned to five groups (n = 5). Group 1 served as the normal control, while groups 2–5 were exposed to 5 mg/kg body weight of cadmium chloride (CdCl 2 ) daily. Group 2 received no treatment, whereas groups 3 and 4 were treated with 200 and 400 mg/kg VSME, respectively, and group 5 received 10 mg/kg propranolol (standard drug), all for 21 days via oral administration. Biochemical and histopathological analyses of the heart were conducted post‐treatment. Cadmium exposure significantly elevated cardiac malondialdehyde, triglycerides, cholesterol, low‐density lipoprotein, creatine kinase, lactate dehydrogenase, and C‐reactive protein, while reducing high‐density lipoprotein, superoxide dismutase (SOD), catalase, and glutathione peroxidase. VSME treatment reversed these changes, restoring antioxidant status, lipid profile, cardiac biomarkers, and myocardial architecture. Molecular docking revealed strong binding affinities of VSME phytochemicals (kaempferol, isorhamnetin, luteolin) with Kelch‐like ECH‐associated protein 1 (Keap1), primarily through hydrogen bonds. These compounds exhibited superior drug‐likeness, pharmacokinetics, and safety profiles compared to the standard Keap1 inhibitor, CPUY192018. These findings suggest that VSME may exert cardioprotective effects partly through antioxidant activity and potential interference with the Keap1‐Nrf2 interaction, as supported by molecular docking.
- Open Access
- 23 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S7) , e108671
Vitex simplicifolia Mitigates Cadmium‐Induced Alzheimer‐like Neurotoxicity through Enzymatic and Neurotransmitter Modulation in Animal Model
Background: Cadmium (Cd) disrupt neurotransmitter homeostasis, leading to significant neurotoxicity. This study investigated the neuroprotective effects of Vitex simplicifolia extract in a CdCl₂‐induced neurotoxicity model. Method: Twenty‐five male Wistar rats were divided into five groups. Group 1 (normal control), while groups 2–5 were administered CdCl₂ (5 mg/kg body weight). Group 2 (untreated), groups 3–5 received ascorbic acid (20 mg/kg b.w.) or V. simplicifolia extract at 200 and 400 mg/kg b.w., respectively, for 21 days via oral administration. Biochemical and histological analyses of brain tissues were performed to assess neurotransmitter levels, enzymatic biomarkers, and neuronal integrity. Result: CdCl₂ exposure significantly (p < 0.05) decreased levels of dopamine (2.88 ± 0.64 ng/100 mL), serotonin (21.45 ± 1.83 ng/mL), acetylcholine (229.34 ± 12.10 U/L), glutamate dehydrogenase (1.03 ± 0.041 U/L), and Na⁺/K⁺‐ATPase activity (2.32 ± 0.52 nmol Pi/min), while increasing monoamine oxidase activity (0.03 ± 0.01 mg/mL) and GABA levels (8.32 ± 0.63 mg/mL), in CdCl₂ model compared to the control group values of 6.37 ± 0.53 ng/100 mL, 42.66 ± 2.98 ng/mL, 299.05 ± 17.18 U/L, 1.91 ± 0.08 U/L, 4.47 ± 0.72 nmol Pi/min, 0.04 ± 0.04 mg/mL, and 5.49 ± 0.48 mg/mL, respectively. Treatment with the extract significantly reversed these neurochemical alterations, restoring neurotransmitter and enzyme levels toward normal. Histological assessments revealed that the extract ameliorated neuronal damage by reducing necrotic cell bodies seen in CdCl₂ exposured rats Conclusion: Thus, V. simplicifolia may serve as a promising therapeutic candidate for mitigating Cd‐induced neurotoxicity through modulation of neurotransmitter levels and enzymatic biomarkers.
- 23 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S7) , e108671
Open AccessVitex simplicifolia Mitigates Cadmium‐Induced Alzheimer‐like Neurotoxicity through Enzymatic and Neurotransmitter Modulation in Animal Model
Background: Cadmium (Cd) disrupt neurotransmitter homeostasis, leading to significant neurotoxicity. This study investigated the neuroprotective effects of Vitex simplicifolia extract in a CdCl₂‐induced neurotoxicity model. Method: Twenty‐five male Wistar rats were divided into five groups. Group 1 (normal control), while groups 2–5 were administered CdCl₂ (5 mg/kg body weight). Group 2 (untreated), groups 3–5 received ascorbic acid (20 mg/kg b.w.) or V. simplicifolia extract at 200 and 400 mg/kg b.w., respectively, for 21 days via oral administration. Biochemical and histological analyses of brain tissues were performed to assess neurotransmitter levels, enzymatic biomarkers, and neuronal integrity. Result: CdCl₂ exposure significantly (p < 0.05) decreased levels of dopamine (2.88 ± 0.64 ng/100 mL), serotonin (21.45 ± 1.83 ng/mL), acetylcholine (229.34 ± 12.10 U/L), glutamate dehydrogenase (1.03 ± 0.041 U/L), and Na⁺/K⁺‐ATPase activity (2.32 ± 0.52 nmol Pi/min), while increasing monoamine oxidase activity (0.03 ± 0.01 mg/mL) and GABA levels (8.32 ± 0.63 mg/mL), in CdCl₂ model compared to the control group values of 6.37 ± 0.53 ng/100 mL, 42.66 ± 2.98 ng/mL, 299.05 ± 17.18 U/L, 1.91 ± 0.08 U/L, 4.47 ± 0.72 nmol Pi/min, 0.04 ± 0.04 mg/mL, and 5.49 ± 0.48 mg/mL, respectively. Treatment with the extract significantly reversed these neurochemical alterations, restoring neurotransmitter and enzyme levels toward normal. Histological assessments revealed that the extract ameliorated neuronal damage by reducing necrotic cell bodies seen in CdCl₂ exposured rats Conclusion: Thus, V. simplicifolia may serve as a promising therapeutic candidate for mitigating Cd‐induced neurotoxicity through modulation of neurotransmitter levels and enzymatic biomarkers.
- Open Access
- 12 November 2025
- Published by SAGE Publications in Natural Product Communications
- Vol. 20 (11)
Protective Effects of Combretum paniculatum Fraction on CCl 4 -Induced Acute Liver Injury
The rising prevalence of liver diseases poses a significant global health challenge. This study evaluates the hepatoprotective and antioxidant potential of the ethyl acetate fraction of Combretum paniculatum (EFCP) against carbon tetrachloride (CCl 4 )-induced hepatotoxicity in albino rats. Phytochemical analysis of EFCP was conducted using spectrophotometry and gas chromatography-mass spectrometry (GC-MS), while its in vitro antioxidant activity was assessed via 2,2-diphenyl-1-picrylhydrazyl (DPPH) and ferric reducing-antioxidant power (FRAP) assays. Rats were divided into five groups: Group 1 (normal control) received no treatment, while Groups 2-5 were administered CCl 4 (100 mg/kg body weight). Group 2 remained untreated, whereas Groups 3-5 received silymarin (100 mg/kg b.w.) or EFCP (100 and 200 mg/kg b.w.) for 14 days. Biochemical and histological analyses were conducted to assess liver and kidney function, lipid profile, oxidative stress markers, and haematological parameters. EFCP was rich in bioactive phytochemicals and exhibited strong antioxidant activity (IC 50 values: 3.47 μg/mL for DPPH, 207.70 μg/mL for FRAP). CCl 4 intoxication significantly increased malondialdehyde (MDA), liver enzymes, bilirubin, and lipid profile markers while depleting antioxidant defenses and high-density lipoprotein cholesterol (HDL-C). Additionally, haematological and kidney function abnormalities were observed. EFCP treatment improved antioxidant status, HDL-C levels, and haematological parameters while reducing MDA, lipid profile, liver, and kidney dysfunction markers. Histopathological analysis revealed restored hepatic architecture with reduced hepatocyte necrosis, tubular degeneration, and inflammation in EFCP-treated groups. These findings suggest that EFCP possesses potent hepatoprotective properties and may serve as a promising therapeutic agent against hepatotoxicity and oxidative stress-related liver damage.
- 12 November 2025
- Published by SAGE Publications in Natural Product Communications
- Vol. 20 (11)
Open AccessProtective Effects of Combretum paniculatum Fraction on CCl 4 -Induced Acute Liver Injury
The rising prevalence of liver diseases poses a significant global health challenge. This study evaluates the hepatoprotective and antioxidant potential of the ethyl acetate fraction of Combretum paniculatum (EFCP) against carbon tetrachloride (CCl 4 )-induced hepatotoxicity in albino rats. Phytochemical analysis of EFCP was conducted using spectrophotometry and gas chromatography-mass spectrometry (GC-MS), while its in vitro antioxidant activity was assessed via 2,2-diphenyl-1-picrylhydrazyl (DPPH) and ferric reducing-antioxidant power (FRAP) assays. Rats were divided into five groups: Group 1 (normal control) received no treatment, while Groups 2-5 were administered CCl 4 (100 mg/kg body weight). Group 2 remained untreated, whereas Groups 3-5 received silymarin (100 mg/kg b.w.) or EFCP (100 and 200 mg/kg b.w.) for 14 days. Biochemical and histological analyses were conducted to assess liver and kidney function, lipid profile, oxidative stress markers, and haematological parameters. EFCP was rich in bioactive phytochemicals and exhibited strong antioxidant activity (IC 50 values: 3.47 μg/mL for DPPH, 207.70 μg/mL for FRAP). CCl 4 intoxication significantly increased malondialdehyde (MDA), liver enzymes, bilirubin, and lipid profile markers while depleting antioxidant defenses and high-density lipoprotein cholesterol (HDL-C). Additionally, haematological and kidney function abnormalities were observed. EFCP treatment improved antioxidant status, HDL-C levels, and haematological parameters while reducing MDA, lipid profile, liver, and kidney dysfunction markers. Histopathological analysis revealed restored hepatic architecture with reduced hepatocyte necrosis, tubular degeneration, and inflammation in EFCP-treated groups. These findings suggest that EFCP possesses potent hepatoprotective properties and may serve as a promising therapeutic agent against hepatotoxicity and oxidative stress-related liver damage.
- Open Access
- 8 October 2025
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 11 (1) , 1-21
Therapeutic potential of Moringa oleifera phytochemicals as modulators of cathepsin B for Alzheimer’s disease management: insights from molecular docking and dynamics simulations
Background: Alzheimer’s disease (AD) presents a significant challenge in healthcare due to its progressive neurodegenerative nature. Current treatments are limited, prompting the search for novel therapeutic strategies. Phytochemicals from medicinal plants offer potential neuroprotective effects, targeting various pathways implicated in AD pathogenesis. Moringa oleifera, known for its diverse health benefits, presents a promising source of phytochemicals with therapeutic potential against AD. This study aimed to investigate the neuroprotective properties of M. oleifera phytochemicals, particularly their interactions with cathepsin B, a novel target in AD pathology. Results: Phytochemical analysis of M. oleifera seed extract revealed the presence of bioactive compounds, including catechin, naringenin, and ellagic acid, among others. Molecular docking simulations identified moringyne and ellagic acid as top candidates for interacting with cathepsin B, showing favorable binding affinities compared to a standard drug (Z-FA.FMK). Furthermore, ADMET prediction indicated favorable pharmacokinetic properties for moringyne and ellagic acid, suggesting their suitability as oral drugs. Molecular dynamics simulations confirmed stable interactions between the identified compounds and cathepsin B over 250 ns, with ellagic acid exhibiting superior stability. MM/GBSA analysis ranked ellagic acid as the most potent inhibitor of cathepsin B, supporting its potential therapeutic efficacy. Conclusion: This study demonstrates the potential of M. oleifera phytochemicals, particularly moringyne and ellagic acid, as novel therapeutic agents against AD through their interaction with cathepsin B. These findings further demonstrate the importance of natural compounds in drug discovery and development for neurodegenerative diseases. Further preclinical and clinical studies are warranted to validate the efficacy and safety of moringyne and ellagic acid in AD treatment.
- 8 October 2025
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 11 (1) , 1-21
Open AccessTherapeutic potential of Moringa oleifera phytochemicals as modulators of cathepsin B for Alzheimer’s disease management: insights from molecular docking and dynamics simulations
Background: Alzheimer’s disease (AD) presents a significant challenge in healthcare due to its progressive neurodegenerative nature. Current treatments are limited, prompting the search for novel therapeutic strategies. Phytochemicals from medicinal plants offer potential neuroprotective effects, targeting various pathways implicated in AD pathogenesis. Moringa oleifera, known for its diverse health benefits, presents a promising source of phytochemicals with therapeutic potential against AD. This study aimed to investigate the neuroprotective properties of M. oleifera phytochemicals, particularly their interactions with cathepsin B, a novel target in AD pathology. Results: Phytochemical analysis of M. oleifera seed extract revealed the presence of bioactive compounds, including catechin, naringenin, and ellagic acid, among others. Molecular docking simulations identified moringyne and ellagic acid as top candidates for interacting with cathepsin B, showing favorable binding affinities compared to a standard drug (Z-FA.FMK). Furthermore, ADMET prediction indicated favorable pharmacokinetic properties for moringyne and ellagic acid, suggesting their suitability as oral drugs. Molecular dynamics simulations confirmed stable interactions between the identified compounds and cathepsin B over 250 ns, with ellagic acid exhibiting superior stability. MM/GBSA analysis ranked ellagic acid as the most potent inhibitor of cathepsin B, supporting its potential therapeutic efficacy. Conclusion: This study demonstrates the potential of M. oleifera phytochemicals, particularly moringyne and ellagic acid, as novel therapeutic agents against AD through their interaction with cathepsin B. These findings further demonstrate the importance of natural compounds in drug discovery and development for neurodegenerative diseases. Further preclinical and clinical studies are warranted to validate the efficacy and safety of moringyne and ellagic acid in AD treatment.
- Open Access
- 29 September 2025
- Published by Academy of Science of South Africa in South African Journal of Science
- Vol. 121 (9/10)
Radical scavenging and antioxidant properties of green zinc oxide nanoparticles from Anacardiumoccidentale leaves
Nanotechnology has become a focal point of interest on the road to disease intervention due to its vast applications in biomedicine and biotechnology. In this study, we evaluated the antioxidant properties of zinc oxide nanoparticles (ZnONPs) synthesised from Anacardium occidentale leaf extracts. The ZnONPs were characterised using UV-Visible and Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), scanning electron microscopy with energy dispersive X-ray (SEM-EDX), transmission electron microscopy (TEM) and gas chromatography-flame ionisation detection (GC-FID). Maximum UV-Vis spectra absorption revealed a prominent peak at 364–365 nm. The FTIR showed characteristic peaks at 3202 cm-1, with the O-H functional vibration of carboxylic acids, and 1197 cm-1, confirming the C-O stretch of alcohols. The absorption band of Zn tetrahedral coordination and Zn-O occurred at 869 cm-1 and 731–820 cm-1, respectively. The ZnONPs particle size was 17.19 nm while SEM-EDX revealed the crystalline nature and elemental compositions of the ZnONPs. TEM showed particle size distribution to be within 10–29 nm, while GC-FID revealed the presence of flavonoids, alkaloids and polyphenolic compounds. ZnONPs exhibited high antioxidant properties using 2,2-diphenyl-1-picrylhydrazyl, 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonic, nitric oxide, thiobarbituric acid reactive substances, and ferric reducing antioxidant potential. Our findings show that A. occidentale leaves are a promising source of bioreductants for green synthesis, while the robust antioxidant properties exhibited by the ZnONPs are favourable in biomedical applications.
- 29 September 2025
- Published by Academy of Science of South Africa in South African Journal of Science
- Vol. 121 (9/10)
Open AccessRadical scavenging and antioxidant properties of green zinc oxide nanoparticles from Anacardiumoccidentale leaves
Nanotechnology has become a focal point of interest on the road to disease intervention due to its vast applications in biomedicine and biotechnology. In this study, we evaluated the antioxidant properties of zinc oxide nanoparticles (ZnONPs) synthesised from Anacardium occidentale leaf extracts. The ZnONPs were characterised using UV-Visible and Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), scanning electron microscopy with energy dispersive X-ray (SEM-EDX), transmission electron microscopy (TEM) and gas chromatography-flame ionisation detection (GC-FID). Maximum UV-Vis spectra absorption revealed a prominent peak at 364–365 nm. The FTIR showed characteristic peaks at 3202 cm-1, with the O-H functional vibration of carboxylic acids, and 1197 cm-1, confirming the C-O stretch of alcohols. The absorption band of Zn tetrahedral coordination and Zn-O occurred at 869 cm-1 and 731–820 cm-1, respectively. The ZnONPs particle size was 17.19 nm while SEM-EDX revealed the crystalline nature and elemental compositions of the ZnONPs. TEM showed particle size distribution to be within 10–29 nm, while GC-FID revealed the presence of flavonoids, alkaloids and polyphenolic compounds. ZnONPs exhibited high antioxidant properties using 2,2-diphenyl-1-picrylhydrazyl, 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonic, nitric oxide, thiobarbituric acid reactive substances, and ferric reducing antioxidant potential. Our findings show that A. occidentale leaves are a promising source of bioreductants for green synthesis, while the robust antioxidant properties exhibited by the ZnONPs are favourable in biomedical applications.
- Open Access
- 7 November 2024
- Published by International Society of Global Health in Journal of Global Health Economics and Policy
- Vol. 4
Does expanding health insurance in rural Nigeria result in improved health outcomes and poverty reduction?
The recent surge in enrolment in Nigeria’s National Health Insurance Scheme (NHIS) of 11% in Q4 of 2023 presents a critical opportunity to assess its potential for improving healthcare outcomes and reducing poverty, particularly in rural areas. Given the significant healthcare infrastructure and personnel disparities across Nigeria’s rural regions, this paper investigates whether health insurance can effectively achieve these goals. We stress the importance of workforce development in this context. Despite the theoretical advantages of health insurance in enhancing access to care and alleviating financial burdens, its impact in rural areas is severely constrained by a lack of healthcare professionals and facilities. These systemic deficits limit access to quality care, undermining the potential benefits of expanded insurance coverage. We argue that while expanding health insurance is essential, it is insufficient to generate substantial improvements in health outcomes or meaningful poverty reduction without concurrent investments in healthcare infrastructure and workforce development. Furthermore, we propose a phased strategy that prioritizes strengthening healthcare facilities and increasing the availability of healthcare professionals in rural areas, followed by broader insurance coverage expansion. This approach ensures that the gains from health insurance translate into real improvements in healthcare access, outcomes, and long-term poverty reduction, thereby enhancing services for underserved populations.
- 7 November 2024
- Published by International Society of Global Health in Journal of Global Health Economics and Policy
- Vol. 4
Open AccessDoes expanding health insurance in rural Nigeria result in improved health outcomes and poverty reduction?
The recent surge in enrolment in Nigeria’s National Health Insurance Scheme (NHIS) of 11% in Q4 of 2023 presents a critical opportunity to assess its potential for improving healthcare outcomes and reducing poverty, particularly in rural areas. Given the significant healthcare infrastructure and personnel disparities across Nigeria’s rural regions, this paper investigates whether health insurance can effectively achieve these goals. We stress the importance of workforce development in this context. Despite the theoretical advantages of health insurance in enhancing access to care and alleviating financial burdens, its impact in rural areas is severely constrained by a lack of healthcare professionals and facilities. These systemic deficits limit access to quality care, undermining the potential benefits of expanded insurance coverage. We argue that while expanding health insurance is essential, it is insufficient to generate substantial improvements in health outcomes or meaningful poverty reduction without concurrent investments in healthcare infrastructure and workforce development. Furthermore, we propose a phased strategy that prioritizes strengthening healthcare facilities and increasing the availability of healthcare professionals in rural areas, followed by broader insurance coverage expansion. This approach ensures that the gains from health insurance translate into real improvements in healthcare access, outcomes, and long-term poverty reduction, thereby enhancing services for underserved populations.
- Open Access
- 7 November 2024
- Published by International Society of Global Health in Journal of Global Health Economics and Policy
- Vol. 4, e2024007
Does expanding health insurance in rural Nigeria result in improved health outcomes and poverty reduction?
The recent surge in enrolment in Nigeria’s National Health Insurance Scheme (NHIS) of 11% in Q4 of 2023 presents a critical opportunity to assess its potential for improving healthcare outcomes and reducing poverty, particularly in rural areas. Given the significant healthcare infrastructure and personnel disparities across Nigeria’s rural regions, this paper investigates whether health insurance can effectively achieve these goals. We stress the importance of workforce development in this context. Despite the theoretical advantages of health insurance in enhancing access to care and alleviating financial burdens, its impact in rural areas is severely constrained by a lack of healthcare professionals and facilities. These systemic deficits limit access to quality care, undermining the potential benefits of expanded insurance coverage. We argue that while expanding health insurance is essential, it is insufficient to generate substantial improvements in health outcomes or meaningful poverty reduction without concurrent investments in healthcare infrastructure and workforce development. Furthermore, we propose a phased strategy that prioritizes strengthening healthcare facilities and increasing the availability of healthcare professionals in rural areas, followed by broader insurance coverage expansion. This approach ensures that the gains from health insurance translate into real improvements in healthcare access, outcomes, and long-term poverty reduction, thereby enhancing services for underserved populations.
- 7 November 2024
- Published by International Society of Global Health in Journal of Global Health Economics and Policy
- Vol. 4, e2024007
Open AccessDoes expanding health insurance in rural Nigeria result in improved health outcomes and poverty reduction?
The recent surge in enrolment in Nigeria’s National Health Insurance Scheme (NHIS) of 11% in Q4 of 2023 presents a critical opportunity to assess its potential for improving healthcare outcomes and reducing poverty, particularly in rural areas. Given the significant healthcare infrastructure and personnel disparities across Nigeria’s rural regions, this paper investigates whether health insurance can effectively achieve these goals. We stress the importance of workforce development in this context. Despite the theoretical advantages of health insurance in enhancing access to care and alleviating financial burdens, its impact in rural areas is severely constrained by a lack of healthcare professionals and facilities. These systemic deficits limit access to quality care, undermining the potential benefits of expanded insurance coverage. We argue that while expanding health insurance is essential, it is insufficient to generate substantial improvements in health outcomes or meaningful poverty reduction without concurrent investments in healthcare infrastructure and workforce development. Furthermore, we propose a phased strategy that prioritizes strengthening healthcare facilities and increasing the availability of healthcare professionals in rural areas, followed by broader insurance coverage expansion. This approach ensures that the gains from health insurance translate into real improvements in healthcare access, outcomes, and long-term poverty reduction, thereby enhancing services for underserved populations.
- Open Access
- 3 November 2024
- Published by International Journal of Secondary Metabolite in International Journal of Secondary Metabolite
- Vol. 11 (4) , 633-645
Deciphering the therapeutic actions of Brenania brieyi (Rubiaceae) fractions on oxidoinflammatory anomalies
A decline in the antioxidant network during the inflammatory response plays a critical role in the pathogenesis of numerous diseases. We designed this study to decipher the therapeutic efficacy of Brenania brieyi in reducing oxidative stress caused by the inflammatory response to cotton pellets. Graded doses of methanol and chloroform fractions of B. brieyi (MFBB and CFBB) and indomethacin were administered to Wistar rats for seven days after implanting sterilised cotton pellets (20 mg). Thereafter, biochemical indices of oxidative stress were determined using blood samples taken through cardiac puncture. Furthermore, molecular interactions, drug-likeness, and toxicity features of B. brieyi phytochemicals were also assessed. Compared with the untreated group, the groups treated with MFBB and CFBB had a significant (p < 0.05) decrease in granuloma tissue weight and MDA levels while increasing glutathione levels, SOD, and CAT activities. In addition, a substantial increase in inflammatory-induced changes in antioxidant nutrients, together with a decline in liver enzymes, was obtained in the treated groups. The docking tests revealed that the top-scoring phytoconstituents of B. brieyi, n-hexadecanoic acid, and 9-octadecanoic acid interacted well with catalase, having docking scores of -6.19 and -7.58 kcal/mol, respectively. Moreover, the hits had good oral drug-likeness features and a safe toxicity profile. The findings of the study provide evidence that B. brieyi has antioxidant and anti-inflammatory properties, suggesting that it could be used as an alternative therapy to regulate oxidative stress-related diseases.
- 3 November 2024
- Published by International Journal of Secondary Metabolite in International Journal of Secondary Metabolite
- Vol. 11 (4) , 633-645
Open AccessDeciphering the therapeutic actions of Brenania brieyi (Rubiaceae) fractions on oxidoinflammatory anomalies
A decline in the antioxidant network during the inflammatory response plays a critical role in the pathogenesis of numerous diseases. We designed this study to decipher the therapeutic efficacy of Brenania brieyi in reducing oxidative stress caused by the inflammatory response to cotton pellets. Graded doses of methanol and chloroform fractions of B. brieyi (MFBB and CFBB) and indomethacin were administered to Wistar rats for seven days after implanting sterilised cotton pellets (20 mg). Thereafter, biochemical indices of oxidative stress were determined using blood samples taken through cardiac puncture. Furthermore, molecular interactions, drug-likeness, and toxicity features of B. brieyi phytochemicals were also assessed. Compared with the untreated group, the groups treated with MFBB and CFBB had a significant (p < 0.05) decrease in granuloma tissue weight and MDA levels while increasing glutathione levels, SOD, and CAT activities. In addition, a substantial increase in inflammatory-induced changes in antioxidant nutrients, together with a decline in liver enzymes, was obtained in the treated groups. The docking tests revealed that the top-scoring phytoconstituents of B. brieyi, n-hexadecanoic acid, and 9-octadecanoic acid interacted well with catalase, having docking scores of -6.19 and -7.58 kcal/mol, respectively. Moreover, the hits had good oral drug-likeness features and a safe toxicity profile. The findings of the study provide evidence that B. brieyi has antioxidant and anti-inflammatory properties, suggesting that it could be used as an alternative therapy to regulate oxidative stress-related diseases.
- Open Access
- 2 October 2024
- Published by Elsevier in Food Chemistry Advances
- Vol. 5
Exploring the Physicochemical Properties, Functional Nutrition and Fatty Acids Characterization of Myrianthus arboreus Seed Oil as a Novel Lipid Source
- 2 October 2024
- Published by Elsevier in Food Chemistry Advances
- Vol. 5
Open AccessExploring the Physicochemical Properties, Functional Nutrition and Fatty Acids Characterization of Myrianthus arboreus Seed Oil as a Novel Lipid Source